Our proprietary MXMO™ platform was designed to create macrocycles that can reach targets that conventional medications cannot.
The highly selective nature of macrocycles give them the potential to transcend the entire cancer therapy experience, including more comfort and fewer side effects during and after treatment.
Subscribe to our News Alerts